Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine. [electronic resource]
Producer: 20140113Description: 814-9 p. digitalISSN:- 1473-5687
- Adenine -- adverse effects
- Antiviral Agents -- adverse effects
- Biomarkers -- blood
- Chi-Square Distribution
- DNA, Viral -- blood
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Genotype
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- diagnosis
- Humans
- Organophosphonates -- adverse effects
- Phenotype
- Telbivudine
- Thymidine -- adverse effects
- Time Factors
- Treatment Outcome
- Viral Load
- Virus Replication -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.